Parameter | Developmental stage | Control Merged | Control Montanide | Control SjGST | CHI-GST (% reduction) | TSP1-GSTÂ +Â TSP2 (% reduction) | RPP0 (% reduction) | PK4 (% reduction) |
---|---|---|---|---|---|---|---|---|
Ingested blood (mg) | Males | 32.2 ± 6.0 | 32.1 ± 5.1 | 32.3 ± 6.5 | 29.4 ± 0.4 (8.4) | 30.9 ± 1.1 (3.8) | 30.1 ± 2.5 (6.2) | 26.4 ± 1.0 (17.8)* |
Females | 203.6 ± 20.4 | 204.9 ± 20.7 | 202.3 ± 20.1 | 159.0 ± 133.0 (22.4)* | 198.1 ± 14.6 (3.3) | 193.6 ± 18.0 (5.5) | 192.2 ± 16.0 (6.2) | |
Nymphs-3 | 45.8 ± 6.1 | 45.8 ± 4.5 | 45.9 ± 7.0 | 41.5 ± 2.9 (9.3) | 44.1 ± 1.2 (3.6) | 45.6 ± 5.7 (0.5) | 37.3 ± 1.2 (18.6)* | |
Mortality (%) | Males | 6.4 ± 4.5 | 5.9 ± 7.1 | 6.8 ± 0.3 | 6.7 ± 7.3 | 6.7 ± 2.8 | 6.0 ± 8.5 | 4.4 ± 1.5 |
Females | 5.5 ± 2.7 | 6.6 ± 0 | 4.3 ± 3.3 | 6.3 ± 0 | 4.2 ± 3.0 | 2.1 ± 3.0 | 2.1 ± 3.0 | |
Nymphs-3 | 2.0 ± 1.7 | 2.0 ± 2.0 | 2.0 ± 1.7 | 0.7 ± 1.0 | 3.3 ± 3.4 (1.3) | 0.7 ± 0.9 | 1.9 ± 1.6 | |
Moulting (%) | Nymphs-3 | 67.2 ± 1.7 | 66.2 ± 1.7 | 68.2 ± 1.3 | 63.4 ± 36.5 (4.1) | 61.8 ± 8.4 (6.6) | 72.0 ± 4.0 | 57.4 ± 3.6 (13.3)* |
Oviposition (no. eggs/female) | Females | 197.3 ± 18.8 | 203.0 ± 23.0 | 191.0 ± 12.0 | 158.0 ± 2324 (22.2)** | 182.0 ± 14.0 (10.3) | 192.0 ± 14.0 (5.4) | 191.0 ± 6.7 (5.9) |
Fertility (no. nymphs/female) | Females | 179.9 ± 15.8 | 181.0 ± 21.1 | 179.0 ± 20.0 | 148.0 ± 21.0 (18.2)* | 170.0 ± 15.0 (6.0) | 179.0 ± 20.0 (1.1) | 180.0 ± 7.0 (0.5) |
Efficacy (%) | Â | Â | Â | Â | 19.6 | 11.1 | 0 | 8.1 |